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Soil solutions. New approaches to lead cleanup take into account
the particular sensitivities of children to lead's effects. Statistics:
SEGH Task Force on Lead in Soil
involved mice with a Min (multiple intesti-
nal neoplasia) mutation in a gene that
appears to be involved in human colon
cancers. This mutation predisposes mice to
intestinal tumors, and mammary tumors in
the presence of ethylnitrosourea, an alky-
lating agent that damages DNA. Moser
and colleagues also identified a gene,
named MOM-1 (modifier of Min-1) that
reduces the number of tumors the mice
will get due to the Min-1 mutation.
Scientists from the M.D. Anderson
Cancer Center at the University ofTexas
Medical Center presented epidemiological
research on the inheritance of germline
p53 mutations which suggests that envi-
ronmental factors may affect the develop-
ment of tumors. Epidemiologist Louise
Strong and colleagues characterized the
incidence of Li-Fraumeni Syndrome-type
soft tissue sarcomas and osteosarcomas in
20 U.S. and Canadian families not previ-
ously identified as cancer carriers. 'When
looking at families ofchildren (aged 6-16)
who had Li-Fraumeni syndrome, Strong
found that the parents and grandparents of
these children also developed Li-Fraumeni-
type cancers later in life (in their 50s and
60s). This finding is significant because it
may show that environmental factors are
acting on the increased genetic instability
due to the p53 mutations passed through
the germline causing these cancers to occur
at younger and younger ages in consecutive
generations. According to Strong, this
approach to studying families may allow
researchers to determine can-
cer risk by sex, generation,
mutation type, and cancer
site in carriers of p53 germ-
line mutations.
Research presented byJeff
Boyd of the University of
Pennsylvania Medical Center
may be useful in determining
which women with endome-
trial cancer will have a poor
prognosis from the disease.
Boyd has identified a muta-
tion in chromosome 14q that
correlates with terminal type
II endometrial cancers. Scien-
tists may potentially use this
genetic marker as a prognos-
tic tool. This mutation may
also be involved in the devel-
opment of other estrogen-
related cancers as well.
Epidemiologist Barbara S.
Hulka of the University of
North Carolina School of
Public Health provided an
update on the relative risk to
women ofcancer from expo-
sure to exogenous estrogens
through use of oral contra-
ceptives and estrogen replacement therapy
(ERT). Hulka stated that use ofERT over
periods of 10-15 years may increase the
risk of endometrial cancer by as much as
10-fold; however, this risk may be reduced
or eliminated by adding progestin to the
therapy. Similarly, use of combined estro-
gen/progestin oral contraceptives for 3-5
years also reduces the risk of endometrial
cancer to half that of nonusers. However,
women who begin use of combination
product oral contraceptives as teenagers
may slightly increase their risk of breast
cancer.
Paules said ofthe meeting, "I think it is
really important for cancer researchers to
see the diversity of research. We get very
focused on our own little areas ... It's real-
ly important to step back and look at the
broader picture of cancer research to see
how to better design our experiments and
where we fit in." Over 250 scientists
attended the conference, which was co-
sponsored by Burroughs Wellcome, the
Chemical Industry Institute ofToxicology,
the Genotoxicity and Environmental
Mutagen Society, Glaxo, the North
Carolina Biotechnology Center, and
Procter & Gamble.
Taking the Lead on Lead
"In some cases soil cleanup benefits human
health, but in other cases, a community
may panic, spend millions of dollars on
cleanup, then find it hasn't helped," said
Bobby Wixson, chairman of the interna-
tional Society for Environmental
Geochemistry and Health task force on
lead in soil, in announcing a new approach
to lead cleanup.
SEGH's report, which calls for a flexi-
ble, case-by-case approach to risk assess-
ment for lead in soil, is the result of six
years ofstudy ofthe issue by the task force,
which included scientists, physicians, envi-
ronmental regulators, and industry repre-
sentatives. "This is the most comprehen-
sive scientific study to date on this issue,"
said Brian E. Davies, an internationally
recognized soil scientist and co-chairman
ofthe SEGH task force.
The task force proposes an approach
which moves away from the "dirt-eating
child" test for what levels of lead may
remain in soil, to a formula that takes into
account factors such as the future use of
the property (for example, as an industrial
site versus a playground); actual levels of
lead in the blood ofaffected people in the
area; bioavailability of lead-that is, its
ability to be absorbed by the body-which
varies with lead's composition and particle
size; and economic factors. Wixson said,
"This system will help communities decide
the best use of their money to protect the
most people."
According to the SEGH report, as of
1993, lead had been found at 922 of the
1,300 Superfund sites slated for priority
cleanup bythe EPA. However, factors such
as pollution from leaded gasoline, flaking
lead paint, and other sources oflead conta-
mination complicate cleanup issues.
The EPA estimates that 12 million
U.S. children under age 6 may be exposed
to soil with high levels of toxic lead.
Because health effects oflead exposure may
include reduced intelligence and growth in
children, miscarriage and premature birth
in pregnant women, and lowered birth
weight and decreased mental ability in
infants born to exposed mothers, the EPA
considers lead poisoning to be the most
serious environmental health threat to
young children.
Panelist Rufus Chaney of the USDA's
Agricultural Research Service estimates
more than 23% ofurban gardens may con-
tain more than 500 ppm oflead. Studies at
Central Michigan University indicate the
problem is not just urban, citing findings
ofmedian lead levels in soil near the foun-
dation of older homes of 960 ppm.
Currently, under EPA standards, soil with
more than 500 to 1,000 parts per million
of lead is considered hazardous and
cleanup is recommended. The SEGH
panel opposes setting a single ceiling for
lead in soil above which cleanup would be
recommended, preferring a case-by-case
approach.
912 Environmental Health Perspectivesum-WAIVKOJAPOM
According to the SEGH report, the
task force's proposed formula allows for
future adjustment and is also flexible
enough to be used internationally, though
environmental standards for lead vary from
country to country. "Still," said Davies,
"our result is a starting point, not an end
point. We need to test these guidelines in
real-world situations. New information
will change some of the current concepts.
That's the way it should be."
To MTBE or Not to MTBE
Current efforts to protect people from the
dangers of carbon monoxide may be doing
more harm than good. In response to find-
ings that levels of carbon monoxide were
unusually high throughout U.S. cities, the
EPA mandated in 1992 that every state add
the oxygenates ethanol and methyl tertiary
butyl ether (MTBE) to gasoline to reduce
carbon monoxide emissions in problem
areas. The additives are used during the
winter months, when carbon monoxide
emissions are highest.
A year after the onset ofthe oxygenated
fuels program, the results in some states
haven't been what the EPA expected. North
Carolina is one state where the program has
not significantly reduced carbon monoxide
emissions.
In addition, studies have shown that
MTBE may be a carcinogen. The toxicity of
MTBE has become a major concern
because inhalation exposure to the com-
pound is widespread. There is also potential
for contamination of drinking water from
gasoline spills and leakage from under-
ground storage tanks.
Two studies have found that MTBE
causes tumors in mice and rats. An inhala-
tion study, conducted by H.D. Burleigh-
Flayer and colleagues at the Bushy Run
Research Center, Union Carbide Chemicals
and Plastics Company, Inc.,
in 1992 exposed groups of
50 CD-1 male and female
mice to MTBE at concen-
trations of 400, 3,000, and
8,000 parts per million
(ppm) for 6 hours a day, 5
days a week, for 18 months.
The MTBE caused an
increase of liver tumors at
the highest dose. There was
a statistically significant
increase in adenomas in
female mice, and a statisti-
cally significant increase in
carcinomas in male mice.
However, the study had to
be terminated early (at 18
months rather than 24
months as planned) due to
high-dose toxic effects.
Therefore, whether MTBE would have
affected mice in the lower-dose groups ifthe
study had continued is not known.
In an inhalation study conducted by
J.S. Chun and co-workers, also of Bushy
Run, in 1992, groups of50 F344 rats were
exposed to MTBE at the same concentra-
tions as in previous study. The low-dose
group was exposed for 24 months, the mid-
dose group for 97 weeks, and the high-dose
group for only 82 weeks, due to toxicity
leading to early mortality. In mid- and
high-dose groups ofmale rats, a statistically
significant increase in interstitial cell testicu-
lar tumors occurred that was clearly dose
related. The number of tumors in control
groups were high, but an increased number
of tumors in the treated groups was appar-
ent. Male rats in mid- and high-dose groups
also developed significant increases in kid-
ney tumors.
Preliminary results from an ongoing
study being conducted by Cesare Maltoni
and colleagues at the Collegium Ramazzini
in Italy also contribute to the weight of
information on the toxicity ofMTBE. This
study subjected Sprague Dawley rats to
MTBE by olive oil gavage for the lifetime of
the rats. Increases in several types oftumors
occurred at 250 milograms per kilogram
(mg/kg) and 1000 mg/kg MTBE, including
malignant sarcomas, testicular Leydig cell
tumors, hemolymphoreticular tumors, and
combined lymphomas and leukemias. Not
all dose groups have been reported.
Although these results are preliminary, they
are notable because tumors are being seen at
much lower concentrations of MTBE than
in the other two studies.
The EPA conducted a risk assessment
study last year using the results of the
Burleigh-Flayer and Chun studies, and tenta-
tively determined that there was no risk to
humans. The EPA conduded that there was
not enough evidence to assess the risk of
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Adding to the problem? New information fuels the debate over oxygenated gasoline.
MTBE because there are no pertinent
human data and stated that the controversy
around the animal studies warranted further
evaluation. The EPA cited "major uncertain-
ties" in the database ofthe rodent research,
pertaining to high-dose toxicity, possible
species specificity, and high spontaneous
background tumor incidence.
The EPA did consider Maltoni's results,
but decided theywere too preliminary at the
time to affect the risk assessment. No final
classification of MTBE was made. MTBE
was assigned a tentative "C" dassification, a
possible human carcinogen, based on limited
evidence.
Although Maltoni's results have yet to
be released, the existing evidence that
MTBE may be a human carcinogen has
led North Carolina officials to question its
use. A report on the public health impact
of the oxygenated fuels program was writ-
ten by the Environmental Epidemiology
Section ofthe North Carolina Department
of Environment, Health and Natural
Resources. The authors of the report con-
cluded that "the oxygenated fuels program
utilizing MTBE does not provide any pub-
lic health benefit in North Carolina at this
time and may indeed be posing an
increased health risk to the public."
The scientific advisory board to the
DEHNR in the Division ofEnvironmental
Management recentlyevaluated the evidence.
The scientific advisory board conducted its
own risk assessment and concluded that,
according to the National Toxicology
Program dassification ofcarcinogenic activi-
ty, there is "someevidence" forcarcinogenici-
ty of MTBE. The board added that if the
details ofthe Maltoni study are released and
reviewed and the preliminary results are con-
firmed, the data may support "dear evidence
ofcarcinogenicity."
The board also took into account that
there are other carcinogens already in gaso-
line, such as benzene (adass "A," or
known carcinogen). An argument
in favor of MTBE use is that it
reduces the amount of benzene in
gasoline. However, as the board
acknowledged, MTBE could act
synergistically with benzene, pro-
ducing adverse health effects.
Because there is no evidence on the
interactions between benzene and
MTBE, the board could not deter-
mine whether the addition of
MTBE alters the chemical compo-
sition of gasoline for the better or
worse.
The board concluded that the
state should consider requesting
that the EPA remove MTBE from
gasoline because ofthe uncertainties
surroundingit.
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